博晖创新：关于公司获得医疗器械注册证的公告

Core Viewpoint - The company, Bohui Innovation, has received a medical device registration certificate from the National Medical Products Administration for its five-item nucleic acid detection kit for reproductive tract pathogens, indicating a significant advancement in its product offerings and potential market impact [2]. Group 1 - The product is a PCR-fluorescent probe method kit for the in vitro qualitative detection of pathogens including Neisseria gonorrhoeae, Chlamydia trachomatis, Ureaplasma urealyticum/Ureaplasma parvum, Mycoplasma hominis, and Mycoplasma genitalium [2]. - The registration certificate number is Guo Xie Zhu Zheng 20263400155, and it is valid until January 22, 2031 [2]. - This product is designed for use with male urethral swabs and female cervical swabs, expanding the company's diagnostic capabilities in the reproductive health sector [2].